KPV is a peptide that has been researched for its ability to modulate inflammatory pathways tied to NF-kB, a master regulator of the inflammatory response, which may reduce the production of pro-inflammatory cytokines while preserving the immune system’s ability to respond to real threats. KPV may support the treatment of chronic skin conditions, autoimmune and immune dysregulation, and joint and post-viral inflammation.